August 6, 2025 · Form 4 insider transaction
Dambkowski Carl sold 2,725 shares of Apogee Therapeutics, Inc. at $37.78 per share, a transaction worth $103.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024.